Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cook gains US nod for Zilver stent trial:

This article was originally published in Clinica

Executive Summary

The US FDA has given Cook permission to start a 20-patient trial of its self-expanding nitinol stent for treating symptomatic vascular disease of the iliac arteries. The Zilver stent incorporates Cook's "Z-Stent" cell design for optimal strength while maintaining a strong, equally distributed radial force throughout the stented area of the artery, says the Bloomington, Indiana firm. It displays excellent kink resistance while conforming to tortuous anatomy and has multiple gold radiopaque markers at each end to enhance visibility under fluoroscopy.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts